mohd izzuan In releasing its Q3 financial results, Bausch Health ( NYSE: BHC ) also boosted its full-year revenue outlook. The company now sees 2024 revenue of $9.5B- $9.
675B. Consensus is $9.49B.
Also, Bausch Health projects adjusted EBITDA of $3.275B - $3.375B.
In Q3, the company.
